Company Description
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes.
The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services.
It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D.
The company’s platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera, or Guardian 4, and wraparound applications and services.
MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California.
| Country | United States |
| Founded | 1983 |
| IPO Date | Mar 6, 2026 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 8,000 |
| CEO | Que Dallara |
Contact Details
Address: 18000 Devonshire Street Northridge, California 91325 United States | |
| Phone | (763) 514-4000 |
| Website | minimed.com |
Stock Details
| Ticker Symbol | MMED |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| IPO Price | $20.00 |
| CIK Code | 0002062583 |
| CUSIP Number | 60365F109 |
| ISIN Number | US60365F1093 |
| Employer ID | 33-3985981 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Que Dallara | Chief Executive Officer and Director Nominee |
| Chad Spooner | Executive Vice President & Chief Financial Officer |
| Ali Dianaty | Executive Vice President, Chief Product & Technology Officer |
| Courtney Nelson Wills | Senior Vice President, General Counsel |
| Gillian Chandrasena | Senior Vice President, Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 27, 2026 | 8-K | Current Report |
| Apr 17, 2026 | 10-Q | Quarterly Report |
| Mar 27, 2026 | 8-K | Current Report |
| Mar 25, 2026 | 8-K | Current Report |
| Mar 9, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 9, 2026 | 8-K | Current Report |
| Mar 6, 2026 | 424B4 | Prospectus |
| Mar 5, 2026 | EFFECT | Notice of Effectiveness |
| Mar 5, 2026 | CERT | Certification by an exchange approving securities for listing |
| Mar 5, 2026 | 8-A12B | Registration of securities |